Please provide your email address to receive an email when new articles are posted on . In the act of balancing venous thromboembolism prophylaxis after total joint arthroplasty, guidelines by the ...

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

There is broad consensus regarding the importance of thromboprophylaxis in hospitalized patients with cancer, including prolonged prophylaxis in high-risk surgical patients. Prophylaxis is not ...

Guidelines for VTE Prophylaxis in Nonsurgical Patients Issued New evidence-based clinical practice guidelines have been issued for the prophylaxis of venous thromboembolism (VTE) in nonsurgical ...

Please provide your email address to receive an email when new articles are posted on . The American College of Physicians has issued a new set of recommendations regarding prophylaxis of VTE among ...

In the updated clinical guidelines for the prevention and treatment of venous thromboembolism (VTE) in cancer patients, released by the American Society of Clinical Oncology (ASCO), the most notable ...

October 31, 2011 — Before starting therapy to prevent venous thromboembolism (VTE), physicians should evaluate the risk for thromboembolism and bleeding among medical, nonsurgical inpatients, ...

In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

A new set of guidelines, developed by AATS and ESTS (European Society for Thoracic Surgery) presented today at the AATS 101st Annual Meeting, recommends a 30-day course of Venous Thromboembolism (VTE) ...

(HealthDay News) — The 2014 recommendations for the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer are unchanged from 2013, according to an article published online ...

"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...